4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037473
President and CEO sold 33,260 shares at an average $21.64 ($719,735)
- President and CEO acquired 73,015 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-01 | Exercise or conversion : show line 1 in the form | +73,015 | 1,265,442 | D | ||
| 2021-06-02 | Sale : show line 2 in the form | −27,743 | $21.51 | $596,696 | 1,237,699 | D |
| 2021-06-02 | Sale : show line 3 in the form | −5,517 | $22.30 | $123,038 | 1,232,182 | D |
| Open-market sales · 33,260 sh · avg $21.64 · $719,735 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-01 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −73,015 | 0 | D |
Loading xslF345X03/doc4.xml…